JB Chemicals & Pharmaceuticals Ltd - 506943 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Submission of Information of loss of share certificate under Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the financial year ended on March 31, 2021. JB Chemicals & Pharmaceuticals Ltd - 506943 - Disclosure Under Regulation 30(5) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Revised contact details of Key Managerial Personnel
JBCPL launches new division offering therapies targeting kidney diseases
The new division will focus exclusively on comprehensive renal care ranging from the management of hypertension in Chronic Kidney Disease to End-stage renal disease, the company said. JB Chemicals & Pharmaceuticals Ltd - 506943 - Press Release
Launch of new dedicated division 'RENOVA' to enter Nephrology segment in India J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Institution Of New Employee Stock Option Scheme
Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Regulations and Disclosure Requirements) Regulations, 2015 read with Part B of Schedule III- Institution of new Employee Stock Option Scheme JB Chemicals & Pharmaceuticals Ltd - 506943 - Statement Of Investor Complaints For The Quarter Ended March 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- M C MehtaDesignation :- Company Secretary and Compliance Officer JB Chemicals & Pharmaceuticals Ltd - 506943 - Shareholding for the Period Ended March 31, 2021
JB Chemicals & Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here JB Chemicals & Pharmaceuticals Ltd - 506943 - Certificate Under Regulation 40(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Certificate under regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 for half year ended March 31, 2021.. J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Compliance Certificate Under Regulation 7(3) For The Half Year Ended March 31, 2021.
Compliance certificate under Regulation 7(3) for the half year ended March 31, 2021.